Human Salivary Histatins: Promising Anti-Fungal Therapeutic Agents
Open Access
- 1 October 1998
- journal article
- other
- Published by SAGE Publications in Critical Reviews in Oral Biology & Medicine
- Vol. 9 (4) , 480-497
- https://doi.org/10.1177/10454411980090040601
Abstract
Histatins constitute a group of small, cationic multifunctional proteins present in the saliva of human and some nonhuman primates. The most significant function of histatins may be their anti-fungal activity against Candida albicans and Cryptococcus neoformans. Histatins have been extensively studied at both the protein and gene levels. The structure-function relationship of histatins with respect to their candidacidal activity has also been studied by means of recombinant histatin variants, as well as by chemically synthesized histatin fragments. The mechanism of histatins' action on Candida albicans is not clear, but it appears to be different from that of azole-based anti-fungal drugs which interrupt ergosterol synthesis. During the past 20 years, fungal infections have become more prevalent as a result of the emergence of AIDS, as well as, paradoxically, modern medical advances. The toxicity of current anti-fungal medicine, the emergence of drug-resistant strains, and the availability of only a few types of anti-fungal agents are the major disadvantages of current anti-fungal therapy. Therefore, the importance of the search for new, broad-spectrum anti-fungals with little or no toxicity cannot be overemphasized. The following properties make histatins promising anti-fungal therapeutic agents: (1) They have little or no toxicity; (2) they possess high cidal activities against azole-resistant fungal species and most of the fungal species tested; and (3) their candidacidal activity is similar to that of azole-based antifungals. Current research efforts focus on the development of improved histatins with enhanced cidal activity and stability, and of suitable and effective histatin delivery systems. These and other approaches may help to outpace the growing list of drug-resistant and opportunistic fungi causing life-threatening, disseminating diseases. The histatins with improved protective properties may also be used as components of artificial saliva for patients with salivary dysfunction.Keywords
This publication has 99 references indexed in Scilit:
- Expression of β-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery systemGene Therapy, 1997
- Salivary Gland Dysfunction: Causes, Symptoms, TreatmentThe Journal of the American Dental Association, 1994
- Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.Proceedings of the National Academy of Sciences, 1993
- mRNAs for PRPs, Statherin, and Histatins in von Ebner's Gland TissuesJournal of Dental Research, 1990
- Genetic protein polymrophisms in human saliva: An interpretive reviewBiochemical Genetics, 1978
- Polyacrylamide Gel Electrophoresis of Human Salivary Histidine-Rich-PolypeptidesJournal of Dental Research, 1977
- Differential antigenicity of human salivary histidine-rich polypeptides in goats and rabbitsArchives of Oral Biology, 1977
- Studies on histidine-rich polypeptides from human parotid salivaArchives of Biochemistry and Biophysics, 1976
- Histones isolated from human parotid fluidBiochemical and Biophysical Research Communications, 1973
- Genetic Polymorphism of Basic Proteins from Parotid SalivaScience, 1972